Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid

Clinical trial NCT02719327 · COMPLETED

Trial details

NCT number: NCT02719327
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2017-06-08
Primary completion: 2023-09-29
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.